Abstract
First study should be a plain X-ray of the affected area, followed by CT or MRI.
You have full access to this open access chapter, Download chapter PDF
Similar content being viewed by others
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
1 Diagnosis
First study should be a plain X-ray of the affected area, followed by CT or MRI. Pulmonary lesions are detected with CT, whereas skeletal foci are detected with bone scan. It is possible that we are currently not staging patients optimally and some metastatic lesions are being misdiagnosed and perhaps other modalities such as total body MRI should be employed. 18F-FDG PET/CT is a useful imaging modality for diagnosis and staging especially in high grade tumors. It is also more sensitive to bone scanning in Ewing sarcomas of the bones. PET is also necessary to distinguish viable residual tumor from necrosis following treatment [1].
2 Staging
For bone sarcomas, the most widely used classification systems are the Musculoskeletal Tumor Society system developed by Enneking in the 1980s and the American Joint Cancer Committee (AJCC) system. They have different scope, since AJCC is related to prognosis and includes some parameters (i.e., size) not encountered in Enneking’s classification, which on the other hand is related to the surgical approach.
3 Surveillance
According to NCCN guidelines, patients should be monitored every 3Â months for the first 2Â years, every 4Â months in the 3rd year, every 6Â months for years 4 and 5 and on an annual basis thereafter. Clinical exam, chest imaging (X-ray or CT) and imaging of the primary site (X-ray, MRI or CT), as well as skeleton screening (bone scan or PET) may be performed in regular intervals. Especially for CS, late recurrences (even after 10Â years) are more common, so patients should be advised and followed-up accordingly.
Reference
Bastiannet E, Groen H, Jager PL, et al (2004) The value of PET/CT scan in the detection grading and response to therapy of soft tissue and bone sarcomas: a systematic review and meta-analysis. Cancer Met Rev 30:83–101
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Italia
About this chapter
Cite this chapter
Papanastassiou, I.D., Demertzis, N.S. (2014). Clinical Implications of Bone Sarcomas. In: Gouliamos, A., Andreou, J., Kosmidis, P. (eds) Imaging in Clinical Oncology. Springer, Milano. https://doi.org/10.1007/978-88-470-5385-4_13
Download citation
DOI: https://doi.org/10.1007/978-88-470-5385-4_13
Published:
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-5384-7
Online ISBN: 978-88-470-5385-4
eBook Packages: MedicineMedicine (R0)